2021 annual financial data
Niagen Bioscience 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -35.82%.
Operating income was -27,073,000 USD and net income was -27,128,000 USD.
Operating cash flow was -24,163,000 USD.
Get free Niagen Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 67,449,000 USD
- Operating income
- -27,073,000 USD
- Net income
- -27,128,000 USD
- Operating cash flow
- -24,163,000 USD